Clinical Trials Directory

Trials / Completed

CompletedNCT03204630

Functional Evaluation of Two Infant Formula Supplemented With Probiotics Isolated From Breast Milk

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
236 (actual)
Sponsor
Biosearch S.A. · Industry
Sex
All
Age
3 Weeks – 5 Weeks
Healthy volunteers
Accepted

Summary

A randomized double blinded controlled study including infants at the age of 1 month . Infants are assigned randomly to either infant formula supplemented with B. breve CECT7263 or L.fermentum CECT5716 (Probiotic groups), or the same formula without the probiotic strain (Control group). The primary outcome of the study is the body weight gain of infants. Secondary outcomes are incidence of infections, symptoms related with intestinal function, and fecal microbiota

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLferProbiotic bacteria originally isolated from breast milk: the strain Lactobacillus fermentum CECT5716
DIETARY_SUPPLEMENTBifidoProbiotic bacteria originally isolated from breast milk: the strain Bifidobacterium breve CECT7263
OTHERControlStandard infant formula

Timeline

Start date
2011-01-01
Primary completion
2014-11-01
Completion
2015-12-01
First posted
2017-07-02
Last updated
2017-07-02

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT03204630. Inclusion in this directory is not an endorsement.

Functional Evaluation of Two Infant Formula Supplemented With Probiotics Isolated From Breast Milk (NCT03204630) · Clinical Trials Directory